Novo Holdings A/S Long-Term Concentrated

CIK: 0001388325 · Show all filings

Period: Q4 2013 (← Previous) (Next →)

Filing Date: Nov 14, 2014

Total Value ($000): $694,947

Holdings (8)

VTI VANGUARD INDEX FDS 41.1%

Value ($000) $285,755 Shares 2,979,100 Est. Cost $57.39 Unrealized —

— OPHTHOTECH CORP 32.2%

Value ($000) $223,554 Shares 6,910,489 Est. Cost $32.35 Unrealized —

VGK VANGUARD INTL EQUITY INDEX F 17.8%

Value ($000) $123,539 Shares 2,101,000 Est. Cost $45.01 Unrealized —

— WRIGHT MED GROUP INC 2.6%

Value ($000) $17,989 Shares 585,759 Est. Cost $23.81 Unrealized —

— TETRAPHASE PHARMACEUTICALS INC 2.3%

Value ($000) $16,224 Shares 1,200,000 Est. Cost $13.52 Unrealized —

— TETRAPHASE PHARMACEUTICALS INC 2.3%

Value ($000) $16,224 Shares 1,200,000 Est. Cost $13.52 Unrealized —

PTCT PTC THERAPEUTICS INC 1.5%

Value ($000) $10,137 Shares 597,359 Est. Cost $17.38 Unrealized +1.1%

— WRIGHT MED GROUP INC 0.2%

Value ($000) $1,525 Shares 4,720,065 Est. Cost $2.50 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
VTI	VANGUARD INDEX FDS	2,979,100	$285,755	41.1%	$57.39	—	—	922908769
—	OPHTHOTECH CORP	6,910,489	$223,554	32.2%	$32.35	—	—	683745103
VGK	VANGUARD INTL EQUITY INDEX F	2,101,000	$123,539	17.8%	$45.01	—	—	922042874
—	WRIGHT MED GROUP INC	585,759	$17,989	2.6%	$23.81	—	—	98235T107
—	TETRAPHASE PHARMACEUTICALS INC	1,200,000	$16,224	2.3%	$13.52	—	—	88164N105
—	TETRAPHASE PHARMACEUTICALS INC	1,200,000	$16,224	2.3%	$13.52	—	—	88165N105
PTCT	PTC THERAPEUTICS INC	597,359	$10,137	1.5%	$17.38	+1.1%	—	69366J200
—	WRIGHT MED GROUP INC	4,720,065	$1,525	0.2%	$2.50	—	—	98235T115